compare glp-1 drugs comparison of glp 1 agonists Table 1 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review GLP-1 Drug Comparison in Diabetes

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

PMID 34815532

These strategies offer several potential advantages over GLP-1 analogs, including a more natural stimulation of GLP-1 pathways, reduced risk of side effects, and the ability to address metabolic dysregulation at its source However, clinical applicability for pharmacological targets to increase sufficient GLP-1 production and promote L-cell differentiation has not been identified

However, according to the CDC, more than 40% of Americans are clinically obese (BMI over 30), which means truly knowing and understanding your options for optimal weight loss is vital in order to make the best decision to improve your health and well-being

Note: These are guideline-based indications at a population level

Vilsbll T, et al